MicroCME: Excipient/Vaccine Allergy
Price: FREE to members; $20 non-members
Length: 20 minutes
This microlearning, presented by Dr. John Kelso, discusses issues surrounding food-derived substances used as excipients in medications.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Allied health professionals
Primary Care Providers
Fellows-in-Training
Learning Objectives
By participating in this course, learners should be able to:
- Describe which food-derived substances are used as pharmaceutical excipients in which medications
- Understand published data regarding the safety of administration of these medications to recipients with food allergy
- Investigate potential allergy to the food component if a particular patient has had an apparent allergic rection to a medication containing it
- To administer mRNA COVID-19 vaccines to patients with suspected or proven PEF allergy without special precautions
Mary Beth Hudelson, MD, FACAAI, planner/reviewer
Joel Klein, MD, FACAAI, planner
Tammy Peng, MD, planner
Desha Jordan, MD, planner
Karen Anstey, MD, planner
Evelyn Lomasney, MD, planner
Deepa Patadia, MD, planner
Brianne Nicole Navetta-Modrov, MD, planner
Farrah Khan, MD, planner
Available Credit
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Attendance